• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Public Health

Moderate chocolate consumption lowers risk of stroke in men

bys25qthea
September 25, 2012
in Public Health, Surgery
Reading Time: 4 mins read
Share on FacebookShare on Twitter

Image: CC/sifu

Key study points:

1.       Higher rates of chocolate intake are associated with decreased risk of stroke.
2.       The inverse association between chocolate consumption and stroke risk is similar between men and women.
 

Primer: There is increasing evidence supporting the cardioprotective effects of chocolate consumption. In fact, studies have suggested that consuming dark chocolate daily may reduce cardiovascular events by as much as 85 per 10,000 population over 10 years time. It is theorized that this health benefit may arise from the flavonoids contained in chocolate, which help decrease levels of reactive oxygen and nitrogen species and inhibit oxidation of low-density lipoprotein (LDL) cholesterol. Further, chocolate has been shown to reduce platelet activation and aggregation, thus decreasing thromboembolism formation. Finally, procyanidins in cocoa have been shown to modulate cytokine expression, this altering the immune response and reducing inflammation.

While several studies have confirmed an association between chocolate consumption and reduced stroke risk, research has largely focused on cocoa’s health effects on women. The authors of this study aimed to examine the association between chocolate consumption and stroke risk in men.

See Also:

–          Cocoa and chocolate flavonoids: implications for cardiovascular health [Journal of the American Diabetic Association]
–          The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model [BMJ]
–          Plasma antioxidants from chocolate [Nature]
 

This [prospective] study: 37,103 Swedish men between 45 and 79 years old were studied. Baseline data, including diet and cardiovascular risk factors (e.g. weight. smoking history, alcohol consumption, aspirin use, history of myocardial infarction, etc.) were collected from each man via mail questionnaires. Each participant was followed until the date of the first stroke event, death, or December 31, 2008, whichever occurred first.

RELATED REPORTS

Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections

Most routine blood tests do not require prolonged fasting

Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases

Baseline data revealed that men in the highest quartile of chocolate consumption were more likely to be younger, leaner, have a university education, abstain from smoking, use aspirin, and consume more alcohol, red meat, and fruits and vegetables compared to the men with the lowest chocolate intake. Of the 37,103 men, there were 1.995 cases of stroke. Men in the highest quartile of chocolate consumption had a 17% lower risk of stroke, even after adjusting for age and other risk factors for stroke. Finally, a meta-analysis conducted by the authors using data from the study and from articles found on a review of two publication databases demonstrated a relative risk of stroke of 0.81 (CI: 0.73-0.99) for people in highest versus lowest levels of chocolate intake.

In sum: The authors of this study conclude that the “high consumption of chocolate is associated with a significant reduced risk of stroke”, with a 17% risk reduction demonstrated by their prospective cohort study and a 19% risk reduction demonstrated in their meta-analysis. These findings are consistent with studies that have previously established the efficacy of chocolate in stroke prevention in women and they provide a clinical correlation to research demonstrating cardioprotective anti-oxidant, anti-clot, and anti-inflammatory benefits of flavonoids. The authors note that the strength of this study comes from its large study population and near-complete follow up. However, they also note several limitations. First, chocolate consumption was calculated from self-reported values and measurements were only taken at one time point (baseline), thus reducing the study validity. Second, the type of chocolate consumed was not assessed. Given that previous studies have suggested reduced health benefit of milk chocolate when compared to dark chocolate and that the majority of chocolate consumed in Sweden is milk chocolate, these findings may have resulted from an unidentified confounder. Indeed, the authors admit that they “cannot exclude the possibility that unmeasured of residual confounding may have affected [their] results.”

Click to read the study in Neurology

By MK

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCALIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

Post-operative mortality rates higher than expected across 28 European nations

Next Post

Four different types of breast cancer revealed based on molecular data

RelatedReports

Infectious Disease

Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections

October 9, 2026
2 Minute Medicine

Most routine blood tests do not require prolonged fasting

October 9, 2026
Artificial Intelligence

Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases

October 9, 2026
Chronic Disease

Low-dose radiotherapy may be effective as a short-term therapeutic option in knee osteoarthritis

October 8, 2026
Next Post

Four different types of breast cancer revealed based on molecular data

Periprocedural anticoagulation: Heparin bridging therapy associated with increased risk of bleeding

CT angiography and non-invasive fractional flow reserve have improved diagnostic accuracy for coronary obstructions

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.